Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gemcitabine hydrochloride lyophilized composition and preparation method thereof

A technology of gemcitabine hydrochloride and composition, applied in the field of gemcitabine hydrochloride freeze-dried composition and preparation thereof, can solve the problems of increased risk of hemolytic reaction, increase product cost, low manufacturing cost, etc., avoid the risk of hemolytic effect, and improve production efficiency , the effect of reducing manufacturing costs

Active Publication Date: 2012-07-18
CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
View PDF7 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] However, the composition still has the following defects. As everyone knows, hemolytic reaction is a common adverse reaction of cyclodextrin. Tests have shown that under the intravenous route, slight hemolysis will occur when the concentration of cyclodextrin reaches 0.02mol / L. Obvious hemolysis occurs at 0.04mol / L, according to the best ratio of inclusion, that is, the pharmaceutical composition is prepared at a ratio of 1:1 with gemcitabine hydrochloride and cyclodextrin molar ratio, gemcitabine hydrochloride cyclodextrin inclusion compound according to The normal dose is very close to the range of hemolytic reaction, and the risk of hemolytic reaction is greatly increased. However, when the clathrate is prepared with a molar ratio of gemcitabine hydrochloride and cyclodextrin at a ratio of 1:2, obvious hemolytic reaction occurs
In addition, due to the high market price of cyclodextrin, the use of too much cyclodextrin greatly increases the cost of the product
[0014] In view of the above, there is a lack of a gemcitabine hydrochloride freeze-dried composition with excellent performance in the prior art, which not only has better quality stability and safety, but also has a preparation process with lower manufacturing costs and high production efficiency.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gemcitabine hydrochloride lyophilized composition and preparation method thereof
  • Gemcitabine hydrochloride lyophilized composition and preparation method thereof
  • Gemcitabine hydrochloride lyophilized composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1 : Preparation of gemcitabine hydrochloride freeze-dried powder injection (the weight ratio of gemcitabine hydrochloride, HP-β-CD, mannitol and sodium acetate is 1:0.45:0.45:0.05; the molar ratio of gemcitabine hydrochloride and HP-β-CD is 1:0.08)

[0047] prescription

[0048] Gemcitabine Hydrochloride 228g HP-β-CD 100g Mannitol 100g Sodium acetate 12.5g Add water for injection to 2500ml Co-made 1000 bottles

[0049] Weigh the raw and auxiliary materials according to the prescription, add water for injection cooled to 25°C, the dosage is 80%, dissolve and stir evenly, adjust the pH to 3.0 with 1mol / L hydrochloric acid or 1mol / L sodium hydroxide solution, and pass the intermediate inspection , add water for injection to make up to the full volume; the solution is filtered through 0.45 μm and 0.22 μm microporous membranes, then sent to the filling room, filled in vials, half-tightened, put on a plate, placed in a fr...

Embodiment 2

[0051] Example 2 : Preparation of gemcitabine hydrochloride freeze-dried powder injection (the weight ratio of gemcitabine hydrochloride, HP-β-CD, glucose and sodium acetate is 1:0.22:0.45:0.05; the molar ratio of gemcitabine hydrochloride and HP-β-CD is 1:0.04)

[0052] prescription

[0053] Gemcitabine Hydrochloride 228g HP-β-CD 50g glucose 100g Sodium acetate 12.5g Add water for injection to 2500ml Co-made 1000 bottles

[0054] The raw and auxiliary materials of the prescription amount were weighed, and the method was the same as in Example 1 to prepare gemcitabine hydrochloride powder injection for injection.

Embodiment 3

[0055] Example 3 : Gemcitabine hydrochloride freeze-dried powder preparation (the weight ratio of gemcitabine hydrochloride, HP-β-CD, lactose and sodium acetate is 1:0.22:0.45:0.05; the molar ratio of gemcitabine hydrochloride and HP-β-CD is 1:0.04)

[0056] prescription

[0057] Gemcitabine Hydrochloride 228g HP-β-CD 50g lactose 100g Sodium acetate 12.5g Add water for injection to 2500ml Co-made 1000 bottles

[0058] The raw and auxiliary materials of the prescription amount were weighed, and the method was the same as in Example 1 to prepare gemcitabine hydrochloride powder injection for injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The invention relates to a gemcitabine hydrochloride lyophilized composition and a preparation method thereof, and aims to solve the technical problems of poor stability and long production cycle in the current gemcitabine hydrochloride lyophilized preparation. The gemcitabine hydrochloride lyophilized composition comprises the following components: gemcitabine hydrochloride, cyclodextrin or cyclodextrin derivative, lyophilized excipient and pH regulator, wherein the weight proportion of the components is 1:0.2-0.55:0.2-0.7:0.01-0.1. The gemcitabine hydrochloride lyophilized composition and the preparation method thereof have the benefits that a proper amount of solubilizer (cyclodextrin or cyclodextrin derivative) is added to the gemcitabine hydrochloride lyophilized composition, so thatthe solubility of gemcitabine hydrochloride can be enhanced, the preparation has good reconfigurability and stability, the production cycle of medicine is shortened, the energy consumption is reduced, the gemcitabine hydrochloride lyophilized composition is convenient to store and transport, and security is provided for clinical medication.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a gemcitabine hydrochloride freeze-dried composition and a preparation method thereof. Background technique [0002] Gemcitabine hydrochloride (gemcitabine hydrochloride) is a pyrimidine antineoplastic drug, its chemical name is 2-deoxy-2,2-difluorodeoxycytidine hydrochloride (β-isomer), and its anti-tumor mechanism is its in vivo Activated by phosphorylation, it becomes an active metabolite, incorporates DNA in cells, and prevents tumor cells from progressing from G1 phase to S phase. Gemcitabine hydrochloride for injection (trade name Gemzar) was developed by Eli Lilly and Company, and was first launched in the United States in 1996. It is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer. [0003] Because gemcitabine hydrochloride has a strong gastrointestinal stimulating effect, it is mainly administered ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K31/7068A61K47/40A61P35/00
Inventor 樊俊红刘峰刘媛媛王芳王彦刘磊娜刘翠艳卜利超
Owner CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products